RxDoctor Payments Data

James Wages, MD

Interventional Pain Medicine · Shreveport, LANPI 1447561857

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,808 of the $3,310 with a category attached, or 84.8%. 18 manufacturers reported payments, led by Nevro Corp. at 32.0% of the total. That places this record below the midpoint for interventional pain medicine clinicians in LA, where the typical reported total is $4,761.

$3,310in general payments, 2019–2025

Across 126 payments — averaging $26.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$1K
  • Saluda Medical Americas, Inc.$356
  • Abbott$320
  • Medtronic$234
  • Curonix LLC$180
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$172
  • plus $990 from 12 others

What the payments were for

  • Travel & lodging$50215%
  • Food & beverage$2,80885%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,310 in reported general payments places this provider in the 35th percentile of 57 interventional pain medicine providers in Louisiana.

See all interventional pain medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$376,633
Medicare patients
906
Services billed
7,895

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,407$29,105
Pregabalin280$9,962
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen173$4,126
Acetaminophen-CodeineAcetaminophen With Codeine165$3,730
Gabapentin378$3,656
Fentanyl23$1,864
Morphine Sulfate44$1,236
Diclofenac Sodium164$1,065
Tramadol Hcl168$997
Tizanidine Hcl95$858
Oxycodone Hcl32$723
Celecoxib59$683
Duloxetine Hcl12$235
Baclofen23$182
Methocarbamol23$99

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →